|
|
Article: Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research.
- Article from:
- PR Newswire
- Article date:
- March 16, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BETHESDA, Md., March 16 /PRNewswire-FirstCall/ -- Micromet, Inc. , a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the publication of six abstracts for poster presentations at the 100th annual meeting of AACR taking place from April 20-24, 2009, in Denver, Colorado.
The following posters will be presented:
1. Lutterbuese, R. et al. (2009). Highly efficient lysis of KRAS- and
BRAF-mutated human colon cancer cells by T cell-engaging BiTE
antibodies derived from anti-EGFR antibodies cetuximab and panitumumab.
AACR Annual Meeting 2009, ...